These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 1967441)

  • 21. Credibility of claims of subgroup effects in randomised controlled trials: systematic review.
    Sun X; Briel M; Busse JW; You JJ; Akl EA; Mejza F; Bala MM; Bassler D; Mertz D; Diaz-Granados N; Vandvik PO; Malaga G; Srinathan SK; Dahm P; Johnston BC; Alonso-Coello P; Hassouneh B; Walter SD; Heels-Ansdell D; Bhatnagar N; Altman DG; Guyatt GH
    BMJ; 2012 Mar; 344():e1553. PubMed ID: 22422832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomisation in clinical trials.
    Ogundipe LO; Boardman AP; Masterson A
    Br J Psychiatry; 1999 Dec; 175():581-4. PubMed ID: 10789358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials.
    Kunz R; Oxman AD
    BMJ; 1998 Oct; 317(7167):1185-90. PubMed ID: 9794851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reporting of meta-analyses of randomized controlled trials with a focus on drug safety: an empirical assessment.
    Hammad TA; Neyarapally GA; Pinheiro SP; Iyasu S; Rochester G; Dal Pan G
    Clin Trials; 2013; 10(3):389-97. PubMed ID: 23508987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
    Moher D; Pham B; Jones A; Cook DJ; Jadad AR; Moher M; Tugwell P; Klassen TP
    Lancet; 1998 Aug; 352(9128):609-13. PubMed ID: 9746022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bibliographic study showed improving methodology of meta-analyses published in leading journals 1993-2002.
    Gerber S; Tallon D; Trelle S; Schneider M; Jüni P; Egger M
    J Clin Epidemiol; 2007 Aug; 60(8):773-80. PubMed ID: 17606172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compliance with the CONSORT checklist in obstetric anaesthesia randomised controlled trials.
    Halpern SH; Darani R; Douglas MJ; Wight W; Yee J
    Int J Obstet Anesth; 2004 Oct; 13(4):207-14. PubMed ID: 15477048
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Study Designs and Sources of Error in Medical Research.
    Kacha AK; Nizamuddin SL; Nizamuddin J; Ramakrishna H; Shahul SS
    J Cardiothorac Vasc Anesth; 2018 Dec; 32(6):2789-2801. PubMed ID: 29571641
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of blinding on treatment effect size estimate in randomized controlled trials of oral health interventions.
    Saltaji H; Armijo-Olivo S; Cummings GG; Amin M; da Costa BR; Flores-Mir C
    BMC Med Res Methodol; 2018 May; 18(1):42. PubMed ID: 29776394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Quality of methodology and reporting of randomized controlled trials of acupuncture for obesity].
    Liu XM; Zhang MM; Du L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):192-4. PubMed ID: 15171560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing quality of reports on randomized clinical trials in nursing journals.
    Parent N; Hanley JA
    Can J Cardiovasc Nurs; 2009; 19(2):25-39. PubMed ID: 19517902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reporting attrition in randomised controlled trials.
    Dumville JC; Torgerson DJ; Hewitt CE
    BMJ; 2006 Apr; 332(7547):969-71. PubMed ID: 16627519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals.
    Schulz KF; Chalmers I; Grimes DA; Altman DG
    JAMA; 1994 Jul; 272(2):125-8. PubMed ID: 8015122
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials.
    Djulbegovic B; Cantor A; Clarke M
    Account Res; 2003; 10(4):301-15. PubMed ID: 14989285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [STRENGTHS AND WEAKNESSES OF RANDOMISED CLINICAL TRIALS: EVOLVING CHANGES ACCORDING TO PERSONALIZED MEDICINE].
    Ernest P; Jandrain B; Scheen AJ
    Rev Med Liege; 2015; 70(5-6):232-6. PubMed ID: 26285444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of unequal randomisation in clinical trials--An update.
    Peckham E; Brabyn S; Cook L; Devlin T; Dumville J; Torgerson DJ
    Contemp Clin Trials; 2015 Nov; 45(Pt A):113-22. PubMed ID: 26027788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Empirical assessment suggests that existing evidence could be used more fully in designing randomized controlled trials.
    Goudie AC; Sutton AJ; Jones DR; Donald A
    J Clin Epidemiol; 2010 Sep; 63(9):983-91. PubMed ID: 20573483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of selection bias in parallel-group controlled clinical trials in dogs and cats: 97 trials (2000-2005).
    Brown DC
    J Am Vet Med Assoc; 2006 Sep; 229(6):990-3. PubMed ID: 16978121
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Checklists are not only for the operating room.
    Connor S
    ANZ J Surg; 2013 Oct; 83(10):704-5. PubMed ID: 24251321
    [No Abstract]   [Full Text] [Related]  

  • 40. Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses.
    Moher D; Cook DJ; Jadad AR; Tugwell P; Moher M; Jones A; Pham B; Klassen TP
    Health Technol Assess; 1999; 3(12):i-iv, 1-98. PubMed ID: 10374081
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.